Christophe P Stove Selected Research

N- (3- oxo- 3- (4- (pyridin- 4- yl)piperazin- 1- yl)propyl)benzo(c)(1,2,5)thiadiazole- 4- sulfonamide

1/2020

Striatal Dopamine D2-Muscarinic Acetylcholine M1 Receptor-Receptor Interaction in a Model of Movement Disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christophe P Stove Research Topics

Disease

4	Neoplasms (Cancer) 01/2020 - 03/2003
3	Seizures (Absence Seizure) 01/2020 - 09/2019
2	Hypothermia 01/2022 - 01/2013
1	Constipation 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Acute Liver Failure (Fulminant Hepatic Failure) 11/2021
1	Hypoxia (Hypoxemia) 11/2021
1	Catalepsy 01/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2020
1	Movement Disorders (Movement Disorder) 01/2020
1	Pathologic Processes 01/2020
1	Onchocerciasis 01/2020
1	Epilepsy (Aura) 01/2020
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2020
1	Nodding Syndrome 01/2020
1	Neuralgia (Stump Neuralgia) 11/2019
1	Multiple Sclerosis 11/2019
1	Obesity 11/2019
1	Pica (Geophagia) 09/2019
1	Disease Progression 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Substance-Related Disorders (Drug Abuse) 01/2018
1	Rheumatoid Arthritis 01/2018
1	Ketosis 05/2017
1	Hyperhomocysteinemia 03/2015
1	Anemia 03/2015
1	Sleep Wake Disorders 03/2013
1	Narcolepsy 03/2013
1	Nausea 03/2013
1	Cataplexy 03/2013
1	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2013
1	Toxoplasmosis 06/2012
1	Malaria 06/2012
1	Carcinoma (Carcinomatosis) 03/2003

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2020 - 04/2008
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020 - 01/2018
2	CannabinoidsIBA 09/2019 - 01/2018
1	NucleosidesIBA 01/2022
1	GuaiacolIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2021
1	EnzymesIBA 11/2021
1	oxalylglycineIBA 11/2021
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 11/2021
1	Chelating AgentsIBA 11/2021
1	Deferoxamine (Desferal)FDA LinkGeneric 11/2021
1	IronIBA 11/2021
1	Proteasome InhibitorsIBA 11/2021
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 11/2021
1	N- (3- oxo- 3- (4- (pyridin- 4- yl)piperazin- 1- yl)propyl)benzo(c)(1,2,5)thiadiazole- 4- sulfonamideIBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Kainic Acid (Kainate)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Reserpine (Serpasil)FDA Link 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Glial Fibrillary Acidic ProteinIBA 01/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2020
1	U 95666EIBA 01/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 11/2019
1	methyl 2- (1- (4- fluorobenzyl)- 1H- indazole- 3- carboxamido)- 3- methylbutanoateIBA 09/2019
1	ElementsIBA 01/2019
1	Ketone BodiesIBA 05/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2015
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 03/2013
1	4-hydroxybutyric acidIBA 03/2013
1	Varenicline (Chantix)FDA Link 01/2013
1	Ethanol (Ethyl Alcohol)IBA 01/2013
1	rubreserineIBA 06/2012
1	GATIBA 06/2012
1	ChromansIBA 03/2003
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 03/2003
1	IsoxazolesIBA 03/2003
1	ChalconesIBA 03/2003
1	KetonesIBA 03/2003
1	CoumarinsIBA 03/2003
1	PyrazolesIBA 03/2003
1	LactonesIBA 03/2003

Therapy/Procedure

1	Analgesia 01/2022